{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:08:43Z","timestamp":1782256123622,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.molcel.2014.01.029","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T12:00:57Z","timestamp":1393502457000},"page":"806-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31"],"prefix":"10.1016","volume":"53","author":[{"given":"Emmanuelle","family":"Vir\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Davalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Git","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaia","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Kouzarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molcel.2014.01.029_bib1","doi-asserted-by":"crossref","first-page":"e1003461","DOI":"10.1371\/journal.pgen.1003461","article-title":"The histone demethylase Jarid1b ensures faithful mouse development by protecting developmental genes from aberrant H3K4me3","volume":"9","author":"Albert","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molcel.2014.01.029_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-11-5","article-title":"miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer","volume":"11","author":"Augoff","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.molcel.2014.01.029_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ijc.10644","article-title":"PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer\/testis antigen?","volume":"101","author":"Barrett","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molcel.2014.01.029_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijc.22673","article-title":"Breast cancer associated transcriptional repressor PLU-1\/JARID1B interacts directly with histone deacetylases","volume":"121","author":"Barrett","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.molcel.2014.01.029_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2005.08.026","article-title":"Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas","volume":"100","author":"Brown","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.molcel.2014.01.029_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/gcc.20549","article-title":"Amplification of 11q13 in ovarian carcinoma","volume":"47","author":"Brown","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.molcel.2014.01.029_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-009-0479-x","article-title":"Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers","volume":"121","author":"Brown","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.molcel.2014.01.029_bib8","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.bjc.6602128","article-title":"Overexpression of the Ets-1 transcription factor in human breast cancer","volume":"91","author":"Buggy","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molcel.2014.01.029_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/boc.201100115","article-title":"MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression","volume":"104","author":"Bullock","year":"2012","journal-title":"Biol. Cell"},{"key":"10.1016\/j.molcel.2014.01.029_bib10","first-page":"1267","article-title":"PLU-1\/JARID1B\/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells","volume":"38","author":"Catchpole","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.molcel.2014.01.029_bib11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jmb.2005.05.047","article-title":"Crystal structure of the ENT domain of human EMSY","volume":"350","author":"Chavali","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.molcel.2014.01.029_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature11925","article-title":"NANOG-dependent function of TET1 and TET2 in establishment of pluripotency","volume":"495","author":"Costa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2014.01.029_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2014.01.029_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature08448","article-title":"JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin","volume":"461","author":"Dawson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2014.01.029_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature12108","article-title":"The shaping and functional consequences of the microRNA landscape in breast cancer","volume":"497","author":"Dvinge","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molcel.2014.01.029_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.embor.7400415","article-title":"Binding of\u00a0EMSY to HP1beta: implications for recruitment of HP1beta and BS69","volume":"6","author":"Ekblad","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molcel.2014.01.029_bib17","doi-asserted-by":"crossref","first-page":"E613","DOI":"10.1073\/pnas.1115029109","article-title":"The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY","volume":"109","author":"Ezell","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2014.01.029_bib18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/jcp.21360","article-title":"Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment","volume":"215","author":"Furlan","year":"2008","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.molcel.2014.01.029_bib19","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1074\/jbc.M805872200","article-title":"Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation","volume":"284","author":"Garapaty","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2014.01.029_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.molmed.2006.10.006","article-title":"MicroRNA expression and function in cancer","volume":"12","author":"Garzon","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molcel.2014.01.029_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in Cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.molcel.2014.01.029_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1023\/A:1018427027270","article-title":"Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines","volume":"15","author":"Gilles","year":"1997","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.molcel.2014.01.029_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0092-8674(03)00930-9","article-title":"EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer","volume":"115","author":"Hughes-Davies","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2014.01.029_bib24","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","article-title":"MicroRNAs in cancer: small molecules with a huge impact","volume":"27","author":"Iorio","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.molcel.2014.01.029_bib25","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2014.01.029_bib26","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-07-5194","article-title":"Exploration of\u00a0tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer","volume":"68","author":"Kozaki","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2014.01.029_bib27","doi-asserted-by":"crossref","first-page":"15633","DOI":"10.1074\/jbc.274.22.15633","article-title":"A novel gene (PLU-1) containing highly conserved putative DNA\/chromatin binding motifs is specifically up-regulated in breast cancer","volume":"274","author":"Lu","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.molcel.2014.01.029_bib28","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1073\/pnas.0803055105","article-title":"A microRNA DNA methylation signature for human cancer metastasis","volume":"105","author":"Lujambio","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molcel.2014.01.029_bib29","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2011.05.006","article-title":"Analysis of the human endogenous coregulator complexome","volume":"145","author":"Malovannaya","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2014.01.029_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejso.2008.06.006","article-title":"MicroRNAs: key players in carcinogenesis and novel therapeutic targets","volume":"35","author":"Mirnezami","year":"2009","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.molcel.2014.01.029_bib31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.molcel.2009.07.020","article-title":"Histone chaperones ASF1 and NAP1 differentially modulate removal of active histone marks by LID-RPD3 complexes during NOTCH silencing","volume":"35","author":"Moshkin","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2014.01.029_bib32","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/jnci\/dji254","article-title":"Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY","volume":"97","author":"Raouf","year":"2005","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.molcel.2014.01.029_bib33","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/1078-0432.CCR-03-0410","article-title":"Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome","volume":"10","author":"Rodriguez","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molcel.2014.01.029_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","article-title":"Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells","volume":"9","author":"Saito","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2014.01.029_bib35","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/bcr3319","article-title":"Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer","volume":"14","author":"Switzer","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.molcel.2014.01.029_bib36","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.4161\/cc.9.11.11843","article-title":"miR-31: a crucial overseer of tumor metastasis and other emerging roles","volume":"9","author":"Valastyan","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.molcel.2014.01.029_bib37","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1242\/jcs.081513","article-title":"Roles for microRNAs in the regulation of cell adhesion molecules","volume":"124","author":"Valastyan","year":"2011","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.molcel.2014.01.029_bib38","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1101\/gad.1832709","article-title":"Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis","volume":"23","author":"Valastyan","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.molcel.2014.01.029_bib39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.cell.2009.03.047","article-title":"A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis","volume":"137","author":"Valastyan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.molcel.2014.01.029_bib40","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1158\/0008-5472.CAN-10-0410","article-title":"Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis","volume":"70","author":"Valastyan","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.molcel.2014.01.029_bib41","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1101\/gad.2004211","article-title":"Activation of miR-31 function in already-established metastases elicits metastatic regression","volume":"25","author":"Valastyan","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.molcel.2014.01.029_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2353\/ajpath.2009.080794","article-title":"MiRNAs and cancer","volume":"174","author":"Visone","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molcel.2014.01.029_bib43","doi-asserted-by":"crossref","first-page":"e54398","DOI":"10.1371\/journal.pone.0054398","article-title":"miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer","volume":"8","author":"Vrba","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molcel.2014.01.029_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T\u00a0cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molcel.2014.01.029_bib45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2007.03.001","article-title":"PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation","volume":"25","author":"Yamane","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molcel.2014.01.029_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr916","article-title":"EMSY links breast cancer gene 2 to the \u2018Royal Family\u2019","volume":"6","author":"Yao","year":"2004","journal-title":"Breast Cancer Res."}],"updated-by":[{"DOI":"10.1016\/j.molcel.2014.03.041","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T00:00:00Z","timestamp":1397088000000}}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276514001129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276514001129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:17:08Z","timestamp":1761092228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276514001129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1097276514001129"],"URL":"https:\/\/doi.org\/10.1016\/j.molcel.2014.01.029","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31","name":"articletitle","label":"Article Title"},{"value":"Molecular Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molcel.2014.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}